Literature DB >> 31390899

Tumor microRNA-126 controls cell viability and associates with poor survival in patients with esophageal adenocarcinoma.

Ela Toxopeus1, N Lynam-Lennon2, K Biermann3, G Dickens1, P E de Ruiter1, Jjb van Lanschot1, J V Reynolds2, Bpl Wijnhoven1, J O'Sullivan2, Ljw van der Laan1.   

Abstract

Entities:  

Keywords:  Esophageal cancer; miR-126; multimodality treatment

Mesh：

Substances：

Year:  2019        PMID： 31390899      PMCID： PMC6802158          DOI： 10.1177/1535370219868671

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  39 in total

1.  Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands.

Authors:  Johan L Dikken; Valery E Lemmens; Michel W J M Wouters; Bas P Wijnhoven; Peter D Siersema; Grard A Nieuwenhuijzen; Johanna W van Sandick; Annemieke Cats; Marcel Verheij; Jan Willem Coebergh; Cornelis J H van de Velde
Journal:  Eur J Cancer       Date:  2012-02-06       Impact factor: 9.162

2.  Targeting key signalling pathways in oesophageal adenocarcinoma: a reality for personalised medicine?

Authors:  Richard R Keld; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 3.  MicroRNAs as regulators of mitochondrial function: role in cancer suppression.

Authors:  Marco Tomasetti; Jiri Neuzil; Lanfeng Dong
Journal:  Biochim Biophys Acta       Date:  2013-09-07

4.  miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2.

Authors:  Chunfang Zhao; Ya Li; Ming Zhang; Yi Yang; Li Chang
Journal:  Hum Cell       Date:  2015-01-14       Impact factor: 4.174

5.  microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway.

Authors:  Jie Gao; Xiao-Li Zhou; Rui-Na Kong; Lian-Mei Ji; Ling-Ling He; Dong-Bao Zhao
Journal:  Exp Mol Pathol       Date:  2015-12-23       Impact factor: 3.362

6.  Prognostic significance of differentially expressed miRNAs in esophageal cancer.

Authors:  Yuxin Hu; Arlene M Correa; Ashraful Hoque; Baoxiang Guan; Fei Ye; Jie Huang; Stephen G Swisher; Tsung Teh Wu; Jaffer A Ajani; Xiao-Chun Xu
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

7.  Integrated genomic characterization of oesophageal carcinoma.

Authors: 
Journal:  Nature       Date:  2017-01-04       Impact factor: 49.962

8.  Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.

Authors:  Yoshimasa Saito; Jeffrey M Friedman; Yoshitomo Chihara; Gerda Egger; Jody C Chuang; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2008-12-29       Impact factor: 3.322

9.  The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort.

Authors:  Torben Frøstrup Hansen; Sanne Kjær-Frifeldt; Søren Morgenthaler; Thorarinn Blondal; Jan Lindebjerg; Anders Jakobsen; Flemming Brandt Sørensen
Journal:  J Transl Med       Date:  2014-09-10       Impact factor: 5.531

10.  MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression.

Authors:  Ming-Hua Hu; Chen-Yang Ma; Xiao-Ming Wang; Chen-Dong Ye; Guang-Xian Zhang; Lin Chen; Jin-Guo Wang
Journal:  Oncotarget       Date:  2016-10-11
View more
  3 in total

1.  Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis.

Authors:  Chengjiao Yao; Yilin Li; Lihong Luo; Qin Xiong; Xiaowu Zhong; Fengjiao Xie; Peimin Feng
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

2.  ANMDA: anti-noise based computational model for predicting potential miRNA-disease associations.

Authors:  Xue-Jun Chen; Xin-Yun Hua; Zhen-Ran Jiang
Journal:  BMC Bioinformatics       Date:  2021-07-02       Impact factor: 3.169

Review 3.  Interplay between Extracellular Matrix and Neutrophils in Diseases.

Authors:  Yanyan Zhu; Yumeng Huang; Qian Ji; Shengqiao Fu; Jia Gu; Ningzheng Tai; Xu Wang
Journal:  J Immunol Res       Date:  2021-07-16       Impact factor: 4.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.